Join to view full profile
1275 York AveNew York, NY 10021
Phone+1 212-639-8001
Dr. Schoder is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Heiko Schoder is a specialist in nuclear medicine based in New York, NY. He completed his residency and fellowship at UCLA in 2000 after graduating from Humboldt University of Berlin, Charite Faculty of Medicine and training in Radiology. Since 2017, he has been serving as Chief of the Molecular Imaging and Therapy Service at Memorial Sloan Kettering Cancer Center. Dr. Schoder is experienced in molecular imaging, including PET/CT and SPECT/CT, theranostics, nuclear stress testing, and medical economics. He has published research in various renowned journals, including work on radiation therapy quality assurance and the detection of cancer recurrences using advanced imaging techniques. Additionally, he plays a significant role in clinical trials concerning advanced imaging methods and therapies for cancers, such as lymphoma, head and neck cancer, prostate cancer and a variety ofother malignacies.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Nuclear Medicine, 1998 - 2000
Humboldt University of Berlin - Charite Faculty of MedicineClass of 1989
Certifications & Licensure
NY State Medical License 2000 - 2028
CA State Medical License 2000 - 2027
NJ State Medical License 2006 - 2027
American Board of Nuclear Medicine Nuclear Medicine
CBNCNuclear Cardiology
Clinical Trials
- Pilot Evaluation of 124I-Iodo-Azomycin Galacto-Pyranoside (*IAZGP) Positron Emission Tomography (PET) in the Imaging of Hypoxic Tumors
- The Use of Breathing Synchronized PET/CT Imaging In the Detection and Quantification of FDG Uptake in Lung Nodules
- The Biodistribution and Potential Diagnostic Ability of 18F FACBC in Patients With Head and Neck, Breast, and Prostate Cancer Start of enrollment: 2006 Apr 25
Publications & Presentations
PubMed
- Diagnostic Value of Routine Delayed Pelvic Imaging for Patients with Biochemical Recurrence of Prostate Cancer UndergoingGa-PSMA PET/CT.Karen Y Jia, Jonathan Kuten, Heather Y Jia, Eric H Bent, Patrick Silveira
Journal of Nuclear Medicine. 2026-08-03 - Enhancing Radiation Therapy Quality Assurance in Lymphoma: A Rigorous Real-Time Central Review Process in AHOD2131.Andrea C Lo, Sarah A Milgrom, Raymond Mailhot Vega, David Hodgson, Heather Chapman
International Journal of Radiation Oncology, Biology, Physics. 2026-07-01 - Impact of Bridging Response on Outcomes after CD19 CAR T-Cell Therapy in Large B-Cell Lymphoma.Beatriz Wills, Sarah Samorodnitsky, Samantha Brown, Jessica R Flynn, Sean Devlin
Transplantation and Cellular Therapy. 2026-06-12
Journal Articles
- CALBG 50604: Risk-Adapted Treatment of Non-Bulky Early Stage Hodgkin Lymphoma Based on Interim PETDavid J Straus, Heiko Schoder, John C Grecula, Eric D Hsi, Leslie L Popplewell, John P Leonard, Craig H Moskowitz, Brad S Kahl, Jonathan W Friedberg, Nancy L Bartlett, Blood
Abstracts/Posters
- High Complete Response Rate Observed with Second-Line Chemo-Immunotherapy with Pembrolizumab and GVD (Gemcitabine, Vinorelbine, and Liposomal Doxorubicin) in Relapsed ...Heiko Schoder, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- A Pilot Study of Brentuximab Vedotin Combined with AVD Chemotherapy and Radiotherapy in Patients with Newly Diagnosed Early Stage, Unfavorable Risk Hodgkin LymphomaHeiko Schoder, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Delayed Neutrophil Engraftment in Patients Receiving Daratumumab As Part of Their First Induction Regimen for Multiple MyelomaHeiko Schoder, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Press Mentions
The SNMMI and EANM Practice Guideline for Renal Scintigraphy in AdultsAugust 8th, 2018
Grant Support
- Theranostic DLL3/PSMA-bi-specific CAR-T cells for prostate cancer therapySLOAN-KETTERING INST CAN RESEARCH2024–2029
Other Languages
- German
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
